PatientsVille.com Logo

PatientsVille

Citalopram Side Effects

Common Citalopram Side Effects


The most commonly reported Citalopram side effects (click to view or check a box to report):

Completed Suicide (673)
Anxiety (336)
Dizziness (314)
Confusional State (312)
Fall (311)
Depression (308)
Overdose (306)
Toxicity To Various Agents (294)
Agitation (282)
Nausea (276)
Hyponatraemia (276)
Cardiac Arrest (271)
Serotonin Syndrome (265)
Headache (251)
Convulsion (231)
Tremor (217)
Suicide Attempt (214)
Respiratory Arrest (209)
Electrocardiogram Qt Prolonged (197)
Fatigue (195)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Citalopram Side Effects Reported to FDA

The following Citalopram reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Citalopram on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Motor Developmental Delay, Dermoid Cyst, Foetal Exposure During Pregnancy
This is a report of a female patient (weight: NA) from DK, suffering from the following symptoms/conditions: NA, who was treated with Citalopram (dosage: 40 Mg, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Motor Developmental Delay
  • Dermoid Cyst
  • Foetal Exposure During Pregnancy
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Citalopram treatment in female patients, resulting in motor developmental delay side effect.

Foetal Heart Rate Deceleration Abnormality, Caesarean Section
This report suggests a potential Citalopram Foetal Heart Rate Deceleration Abnormality, Caesarean Section side effect(s) that can have serious consequences. A 36-year-old female patient (weight: NA) from DK was diagnosed with the following symptoms/conditions: panic disorder and used Citalopram (dosage: 40 Mg) starting Oct 02, 2011. Soon after starting Citalopram the patient began experiencing various side effects, including:
  • Foetal Heart Rate Deceleration Abnormality
  • Caesarean Section
Drugs used concurrently: NA. Although Citalopram demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as foetal heart rate deceleration abnormality, may still occur.

Reproductive Tract Hypoplasia, Male, Micropenis, Hypospadias, Cryptorchism, Small For Dates Baby, Low Birth Weight Baby, Apgar Score Low, Foetal Exposure During Pregnancy
This Reproductive Tract Hypoplasia, Male, Micropenis, Hypospadias, Cryptorchism, Small For Dates Baby, Low Birth Weight Baby, Apgar Score Low, Foetal Exposure During Pregnancy problem was reported by a health professional from DK. A male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Oct 02, 2011 this consumer started treatment with Citalopram (dosage: 40 Mg). The following drugs were being taken at the same time: NA. When commencing Citalopram, the patient experienced the following unwanted symptoms/side effects:
  • Reproductive Tract Hypoplasia, Male
  • Micropenis
  • Hypospadias
  • Cryptorchism
  • Small For Dates Baby
  • Low Birth Weight Baby
  • Apgar Score Low
  • Foetal Exposure During Pregnancy
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as reproductive tract hypoplasia, male, may become evident only after a product is in use by the general population.

Retching, Dyskinesia, Yawning, Middle Insomnia
This is a report of a 40-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: depression and was treated with Citalopram, 20 Mg, Mylan (dosage: Taken By Mouth) starting Feb 22, 2014. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Retching
  • Dyskinesia
  • Yawning
  • Middle Insomnia
This opens a possibility that Citalopram, 20 Mg, Mylan treatment could cause the above reactions, including retching, and some female subjects may be more susceptible.


Suicidal Ideation, Sleep Disorder, Abnormal Behaviour, Depression
A 31-year-old female patient (weight: NA) from DK with the following symptoms/conditions: depression started Citalopram treatment (dosage: 10 Mg Daily) on NS. Soon after starting Citalopram treatment, the subject experienced various side effects, including:
  • Suicidal Ideation
  • Sleep Disorder
  • Abnormal Behaviour
  • Depression
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Citalopram.

Gun Shot Wound, Head Injury
A 72-year-old male patient from US (weight: NA) experienced symptoms, such as: depression and was treated with Citalopram(dosage: NA). The treatment was initiated on Feb 25, 2014. After that a consumer reported the following side effect(s):
  • Gun Shot Wound
  • Head Injury
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Citalopram efficacy:
  • Diazepam


Haematospermia
In this report, Citalopram was administered for the following condition: obsessive-compulsive disorder.A 32-year-old male consumer from IT (weight: NA) started Citalopram treatment (dosage: NA) on Jun 01, 2010.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Haematospermia
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Citalopram treatment could be related to the listed above side effect(s).

Viith Nerve Paralysis
This is a report of the following Citalopram side effect(s):
  • Viith Nerve Paralysis
A 36-year-old female patient from GB (weight: NA) presented with the following condition: NA and received a treatment with Citalopram (dosage: NA) starting: NS.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Citalopram treatment could be associated with the listed above side effect(s).

Suicidal Ideation
This Citalopram (citalopram) report was submitted by a 31-year-old female consumer from GB (weight: NA). The patient was diagnosed with: depression and Citalopram (citalopram) was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Suicidal Ideation
Other drugs used simultaneously:
  • Liothyronine Sodium (liothyronine Sodium)
  • Levothyroxine (levothyroxine)
Those unexpected symptoms could be linked to a Citalopram (citalopram) treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Viith Nerve Paralysis, Facial Paresis, Ophthalmoplegia, Dysgeusia
This is a report of a possible correlation between Citalopram use and the following symptoms/side effect(s):
  • Viith Nerve Paralysis
  • Facial Paresis
  • Ophthalmoplegia
  • Dysgeusia
which could contribute to an assessment of Citalopram risk profile.A 36-year-old female consumer from GB (weight: NA) was suffering from NA and was treated with Citalopram (dosage: NA) starting NS.Other concurrent medications: NA.

Viith Nerve Paralysis, Facial Paresis, Ophthalmoplegia, Dysgeusia
A 36-year-old female patient from DK (weight: NA) presented with the following symptoms: NA and after a treatment with Citalopram (dosage: 20 Mg Daily) experienced the following side effect(s):
  • Viith Nerve Paralysis
  • Facial Paresis
  • Ophthalmoplegia
  • Dysgeusia
The treatment was started on NS. Citalopram was used in combination with the following drugs: NA.This report could alert potential Citalopram consumers.

Suicide Attempt, Crying, Apathy, Tachycardia, Diastolic Hypertension
In this report, a female patient from DE (weight: NA) was affected by a possible Citalopram side effect.The patient was diagnosed with NA. After a treatment with Citalopram (dosage: NA, start date: NS), the patient experienced the following side effect(s):
  • Suicide Attempt
  • Crying
  • Apathy
  • Tachycardia
  • Diastolic Hypertension
The following simultaneously used drugs could have led to this reaction:
  • Opipramol
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Citalopram treatment.

Intentional Self-injury, Sopor
This is a report of a 25-year-old male patient from IT (weight: NA), who used Citalopram (dosage: 15 Ml Total) for a treatment of intentional self-injury. After starting a treatment on Feb 22, 2014, the patient experienced the following side effect(s):
  • Intentional Self-injury
  • Sopor
The following drugs could possibly have interacted with the Citalopram treatment
  • Cymbalta (28 Df Total)
The patient was hospitalized.Taken together, these observations suggest that a Citalopram treatment could be related to side effect(s), such as Intentional Self-injury, Sopor.

Ventricular Tachycardia, Overdose, Mental Status Changes, Serotonin Syndrome, Pyrexia, Intentional Overdose, Unresponsive To Stimuli
This ventricular tachycardia side effect was reported by a physician from US. A 19-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Citalopram (dosage: NA), which was started on NS. Concurrently used drugs:
  • Lamotrigine (lamotrigine)
  • Lorazepam (lorazepam)
  • Aripiprazole (aripiprazole)
  • Lamotrigine (lamotrigine)
When starting to take Citalopram the consumer reported the following symptoms:
  • Ventricular Tachycardia
  • Overdose
  • Mental Status Changes
  • Serotonin Syndrome
  • Pyrexia
  • Intentional Overdose
  • Unresponsive To Stimuli
The patient was hospitalized. These side effects may potentially be related to Citalopram.

Haemangioma, Hydronephrosis, Exposure During Pregnancy
This is a Citalopram side effect report of a male patient (weight:NA) from DE, suffering from the following symptoms/conditions: anxiety disorder, who was treated with Citalopram (dosage:10 [mg/d ], start time: Oct 09, 2012), combined with:
  • Trevilor (75 [mg/d ])
  • Metobeta (100 [mg/d ])
  • L-thyroxin (125 [?g/d ])
  • Fragmin (7500 [ie/d ])
  • Ass 100 (100 [mg/d ])
  • Folio (0.4 [mg/d ])
  • Insuman Basal
, and developed a serious reaction and a haemangioma side effect. The patient presented with:
  • Haemangioma
  • Hydronephrosis
  • Exposure During Pregnancy
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Citalopram treatment in male patients suffering from anxiety disorder, resulting in haemangioma.

Haematospermia
This report suggests a potential Citalopram haematospermia side effect(s) that can have serious consequences. A 32-year-old male patient from IT (weight:NA) was diagnosed with the following health condition(s): obsessive-compulsive disorder and used Citalopram (dosage: 20 Mg Daily) starting Jun 01, 2010. Soon after starting Citalopram the patient began experiencing various side effects, including:
  • Haematospermia
Drugs used concurrently:NA. Although Citalopram demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as haematospermia, may still occur.

Tremor, Night Sweats, Agitation, Insomnia, Dry Mouth, Nausea, Decreased Appetite, Anxiety, Confusional State
This tremor problem was reported by a pharmacist from GB. A 60-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): depression.On Feb 10, 2014 a consumer started treatment with Citalopram (dosage: NA). The following drugs/medications were being taken at the same time: NA. When commencing Citalopram, the patient experienced the following unwanted symptoms /side effects:
  • Tremor
  • Night Sweats
  • Agitation
  • Insomnia
  • Dry Mouth
  • Nausea
  • Decreased Appetite
  • Anxiety
  • Confusional State
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as tremor, may become evident only after a product is in use by the general population.

Dizziness Postural, Nausea, Decreased Appetite, Flat Affect, Tremor
This is a Citalopram side effect report of a 24-year-old female patient (weight: NA) from GB. The patient developed the following symptoms/conditions: depression and was treated with Citalopram (dosage: 20 Mg, 1 In 1 D) starting Feb 09, 2014. Concurrently used drugs:
  • Microgynon
Soon after that, the consumer experienced the following of symptoms:
  • Dizziness Postural
  • Nausea
  • Decreased Appetite
  • Flat Affect
  • Tremor
This opens a possibility that Citalopram could cause dizziness postural and that some female patients may be more susceptible.

Cystitis Noninfective, Dysuria
A 67-year-old female patient (weight: NA) from GB with the following symptoms: anxiety started Citalopram(citalopram) treatment (dosage: 10 Mg, 1 In 1 D) on Dec 06, 2013. Soon after starting Citalopram(citalopram) treatment, the consumer experienced several side effects, including:
  • Cystitis Noninfective
  • Dysuria
. Concurrently used drugs:
  • Amlodipine
  • Bendroflumethiazide
  • Irbesartan
This finding indicates that some patients can be more vulnerable to developing Citalopram(citalopram) side effects, such as cystitis noninfective.

Chest Pain, Urinary Retention
This chest pain side effect was reported by a consumer or non-health professional from GB. A 67-year-old male patient (weight:NA) experienced the following symptoms/conditions: depression,chest pain.The patient was prescribed Citalopram (citalopram) (dosage: 1 D), which was started on 2008. Concurrently used drugs:
  • Rythmodan (disopyramide)
.When starting to take Citalopram (citalopram) the consumer reported symptoms, such as:
  • Chest Pain
  • Urinary Retention
These side effects may potentially be related to Citalopram (citalopram). The patient was hospitalized.

Sopor
This is a report of a 41-year-old male patient (weight: NA) from IT, suffering from the following symptoms/conditions: NA, who was treated with Citalopram (citalopram) (dosage: NA, start time: Jun 06, 2013), combined with:
  • Laroxyl
and developed a serious reaction and side effect(s). The consumer presented with:
  • Sopor
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Citalopram (citalopram) treatment in male patients, resulting in sopor side effect. The patient was hospitalized.


This report suggests a potential Citalopram side effect(s) that can have serious consequences. A 47-year-old female patient (weight: NA) from COUNTRY NOT SPECIFIED was diagnosed with the following symptoms/conditions: NA and used Citalopram (dosage: NA) starting NS. Soon after starting Citalopram the patient began experiencing various side effects, including:
    Drugs used concurrently:
    • Diphenhydramine
    • Lithium
    Although Citalopram demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as death, may still occur.

    Completed Suicide, Cardio-respiratory Arrest
    This Completed Suicide, Cardio-respiratory Arrest problem was reported by a consumer or non-health professional from COUNTRY NOT SPECIFIED. A 47-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Citalopram (dosage: NA). The following drugs were being taken at the same time:
    • Escitalopram
    • Amlodipine
    • Carvedilol
    • Bupropion
    • Acetaminophen/hydrocodone
    When commencing Citalopram, the patient experienced the following unwanted symptoms/side effects:
    • Completed Suicide
    • Cardio-respiratory Arrest
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as completed suicide, may become evident only after a product is in use by the general population.

    Completed Suicide
    This is a report of a 46-year-old female patient (weight: NA) from COUNTRY NOT SPECIFIED. The patient developed the following symptoms/conditions: NA and was treated with Citalopram (dosage: NA) starting NS. Concurrently used drugs:
    • Metoprolol
    • Oxycodone
    • Clonazepam
    • Acetaminophen
    • Ethanol
    Soon after that, the consumer experienced the following side effects:
    • Completed Suicide
    This opens a possibility that Citalopram treatment could cause the above reactions, including completed suicide, and some female subjects may be more susceptible.

    Completed Suicide
    A 50-year-old female patient (weight: NA) from COUNTRY NOT SPECIFIED with the following symptoms/conditions: NA started Citalopram treatment (dosage: NA) on NS. Soon after starting Citalopram treatment, the subject experienced various side effects, including:
    • Completed Suicide
    Concurrently used drugs:
    • Clonidine
    • Labetalol
    • Lisinopril
    • Zolpidem
    • Iron
    This finding indicates that some female patients could be more vulnerable to Citalopram.

    1 of 312 



    Top 10 Citalopram Side Effects for Women

    Women Side EffectsReports
    Completed Suicide 295
    Anxiety 254
    Dizziness 220
    Nausea 207
    Agitation 197
    Headache 196
    Overdose 196
    Confusional State 192
    Hyponatraemia 191
    Depression 189

    Top 10 Citalopram Side Effects for Men

    Men Side EffectsReports
    Completed Suicide 313
    Fall 136
    Toxicity To Various Agents 126
    Confusional State 120
    Depression 119
    Serotonin Syndrome 108
    Overdose 103
    Cardiac Arrest 94
    Tremor 92
    Dizziness 90

    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Citalopram Side Effects

    Did You Have a Citalopram Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Citalopram for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Citalopram Safety Alerts, Active Ingredients, Usage Information

    NDC0054-0062
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameCitalopram
    NameCitalopram
    Dosage FormSOLUTION
    RouteORAL
    On market since20040525
    LabelerRoxane Laboratories, Inc
    Active Ingredient(s)CITALOPRAM HYDROBROMIDE
    Strength(s)10
    Unit(s)mg/5mL
    Pharma ClassSerotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]

    Citalopram Dosage, Warnings, Usage.

    Side Effects reported to FDA: 7792

    Citalopram safety alerts: 2012 2011 2007 2005

    Reported deaths: 943

    Reported hospitalizations: 2058

    Celexa (citalopram hydrobromide) - Drug Safety Communication: Revised Recommendations, Potential Risk of Abnormal Heart Rhythms

     

    [Posted 03/28/2012]

    AUDIENCE: Psychiatry, Cardiology

    ISSUE: FDA is clarifying dosing and warning recommendations for the antidepressant Celexa (citalopram hydrobromide; also available in generic form). In August 2011, FDA issued a Drug Safety Communication (DSC) stating that citalopram should no longer be used at doses greater than 40 mg per day because it could cause potentially dangerous abnormalities in the electrical activity of the heart. Citalopram use at any dose is discouraged in patients with certain conditions because of the risk of QT prolongation, but because it may be important for some of those patients to use citalopram, the drug label has been changed to describe the particular caution that needs to be taken when citalopram is used in such patients. The revised drug label also describes lower doses that should be used in patients over 60 years of age.

    Read the FDA Drug Safety Communication for additional information.

    BACKGROUND: Celexa (citalopram hydrobromide; also available in generic form) is in a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs).

    RECOMMENDATIONS:

    • Citalopram is not recommended for use at doses greater than 40 mg per day because such doses cause too large an effect on the QT interval and confer no additional benefit.
    • Citalopram is not recommended for use in patients with congenital long QT syndrome, bradycardia, hypokalemia, or hypomagnesemia, recent acute myocardial infarction, or uncompensated heart failure. 
    • Citalopram use is also not recommended in patients who are taking other drugs that prolong the QT interval.
    • The maximum recommended dose of citalopram is 20 mg per day for patients with hepatic impairment, patients who are older than 60 years of age, patients who are CYP 2C19 poor metabolizers, or patients who are taking concomitant cimetidine (Tagamet) or another CYP2C19 inhibitor, because these factors lead to increased blood levels of citalopram, increasing the risk of QT interval prolongation and Torsade de Pointes.

    See the FDA Drug Safety Communication for additional recommendations for healthcare professionals and patients.


    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178


    [03/28/2012 - Drug Safety Communication - FDA]

    Previous MedWatch Alert:

    [08/24/2011]

    Latest Citalopram clinical trials